Pelion ranks among the most transparent WSE listed companies
Pelion Healthcare Group has won a distinction in the ranking of companies which excel at reporting ESG (non-financial) data to analysts, investors and other groups of stakeholders. The ranking of companies listed on the WSE and the NewConnect market is based on the “ESG Analysis of Companies in Poland”, prepared by the Association of Stock Exchange Issuers, GES and Accreo Taxand.
Pelion Healthcare Group has joined more than 30 other companies selected from among the 831 names listed on the WSE and NewConnect, winning a distinction in the healthcare category.
According to the organisers, as many as 72.9% of all listed companies (i.e. 606) publish no information on environmental management, while 77% fail to report their CSR performance. Very high reporting figures are seen only in the case of corporate governance, with reports released by a staggering 98.8% of all public companies in Poland.
“The aim behind the project is to enhance the transparency of WSE listed companies. This educational initiative is designed to prepare issuers and financial sector entities for potential legislative changes and the approaching market trends in non-financial reporting,” says Mirosław Kachniewski, President of the Association of Stock Exchange Issuers.
At the same time, the organisers emphasised that companies with a good reporting culture not only achieved very attractive rate of return to risk ratios, but also posted strong profitability even in periods affected by the financial crisis. According to them, this observation should encourage investors to consider ESG information while making investment decisions, especially if their time horizon is long, as in the case of investment and pension funds.
The project is run under the auspices of the Ministry of State Treasury as part of the Civic Ownership campaign, the Polish Financial Supervision Authority, and the Association of Retail Investors.
This is how the authors of the “ESG Analysis of Companies in Poland” project comment on its methodology: “The ESG Analysis of Companies in Poland is the first major project in Poland and Europe which collects and organises non-financial data from every company listed on the Polish stock market. The applied method – GES Risk Rating – relies on international standards relating to sustainable development (e.g. Global Compact, OECD Guidelines for Multinational Enterprises, International Labour Organization conventions, ISO 14001 and SA8000), corruption (FCPA) and occupational safety and health (OHSAS 18001), as well as the Principles of Responsible Investment.”
For further details please contact:
Renata Borkowska-Kubiak
Press Officer for Pelion S.A.
Tel. (+48 42) 200 79 19
Fax (+48 42) 613 35 35
Mobile (+48) 785 858 991
E – mail: renata_borkowska-kubiak@pelion.eu
Pelion S.A., formerly Polska Grupa Farmaceutyczna S.A., has operated on the market for twenty-one years. Initially, it was a local pharmaceutical wholesaler. In 1998, the Company shares were floated on the Warsaw Stock Exchange. Proceeds from the initial public offering fuelled the Company’s dynamic growth and allowed it to embark on consolidation of the pharmaceutical wholesale market. Since its floatation, the Company has secured a top position among domestic distributors of medicinal products. Today, Pelion Healthcare Group is one of the largest groups operating on the healthcare markets in Poland and Lithuania. Its services cover all market segments (wholesale, retail and sale to hospitals) and are targeted at individual patients, pharmacies, hospitals and manufacturers. As a holding company, Pelion S.A. oversees all areas of the Group’s operations, which are conducted by PGF Hurt Sp. z o.o. (wholesale), PGF Urtica Sp. z o.o. (sale to hospitals), CEPD N.V. (retail sale), and Pharmalink Sp. z o.o. (services for manufacturers).
According to the organisers, as many as 72.9% of all listed companies (i.e. 606) publish no information on environmental management, while 77% fail to report their CSR performance. Very high reporting figures are seen only in the case of corporate governance, with reports released by a staggering 98.8% of all public companies in Poland.
“The aim behind the project is to enhance the transparency of WSE listed companies. This educational initiative is designed to prepare issuers and financial sector entities for potential legislative changes and the approaching market trends in non-financial reporting,” says Mirosław Kachniewski, President of the Association of Stock Exchange Issuers.
At the same time, the organisers emphasised that companies with a good reporting culture not only achieved very attractive rate of return to risk ratios, but also posted strong profitability even in periods affected by the financial crisis. According to them, this observation should encourage investors to consider ESG information while making investment decisions, especially if their time horizon is long, as in the case of investment and pension funds.
The project is run under the auspices of the Ministry of State Treasury as part of the Civic Ownership campaign, the Polish Financial Supervision Authority, and the Association of Retail Investors.
This is how the authors of the “ESG Analysis of Companies in Poland” project comment on its methodology: “The ESG Analysis of Companies in Poland is the first major project in Poland and Europe which collects and organises non-financial data from every company listed on the Polish stock market. The applied method – GES Risk Rating – relies on international standards relating to sustainable development (e.g. Global Compact, OECD Guidelines for Multinational Enterprises, International Labour Organization conventions, ISO 14001 and SA8000), corruption (FCPA) and occupational safety and health (OHSAS 18001), as well as the Principles of Responsible Investment.”
For further details please contact:
Renata Borkowska-Kubiak
Press Officer for Pelion S.A.
Tel. (+48 42) 200 79 19
Fax (+48 42) 613 35 35
Mobile (+48) 785 858 991
E – mail: renata_borkowska-kubiak@pelion.eu
Pelion S.A., formerly Polska Grupa Farmaceutyczna S.A., has operated on the market for twenty-one years. Initially, it was a local pharmaceutical wholesaler. In 1998, the Company shares were floated on the Warsaw Stock Exchange. Proceeds from the initial public offering fuelled the Company’s dynamic growth and allowed it to embark on consolidation of the pharmaceutical wholesale market. Since its floatation, the Company has secured a top position among domestic distributors of medicinal products. Today, Pelion Healthcare Group is one of the largest groups operating on the healthcare markets in Poland and Lithuania. Its services cover all market segments (wholesale, retail and sale to hospitals) and are targeted at individual patients, pharmacies, hospitals and manufacturers. As a holding company, Pelion S.A. oversees all areas of the Group’s operations, which are conducted by PGF Hurt Sp. z o.o. (wholesale), PGF Urtica Sp. z o.o. (sale to hospitals), CEPD N.V. (retail sale), and Pharmalink Sp. z o.o. (services for manufacturers).
